Therapeutic potential of curcumin in human prostate cancer - I. curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells

被引:101
作者
Dorai, T [1 ]
Gehani, N [1 ]
Katz, A [1 ]
机构
[1] Columbia Univ Coll Phys & Surg, Dept Urol, New York, NY 10032 USA
关键词
prostate cancer; complimentary medicine; curcumin; turmeric;
D O I
10.1038/sj.pcan.4500399
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In an effort to find an alternative nontoxic means of inducing the apoptosis potential in both androgen-dependent and hormone refractory prostate cancer cells, attention was focused on curcumin (turmeric), traditionally used in medicine and cuisine in India and other south-east Asian countries. The results indicate that curcumin is a novel and potent inducer of apoptosis in both androgen-dependent and androgen-independent prostate cancer cells. This was accomplished by down-regulating apoptosis suppressor proteins and other crucial proteins such as the androgen receptor. It is concluded that curcumin may provide an alternative, nontoxic modality by which the clinician may prevent the progression of prostate cancer to its hormone refractory state or to treat advanced prostate cancer by forcing them to undergo apoptosis.
引用
收藏
页码:84 / 93
页数:10
相关论文
共 60 条
[11]  
DELATAILLE A, IN PRESS BR J UROL
[12]   Diet and its preventive role in prostatic disease [J].
Denis, L ;
Morton, MS ;
Griffiths, K .
EUROPEAN UROLOGY, 1999, 35 (5-6) :377-387
[13]   Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer [J].
DiPaola, RS ;
Zhang, HY ;
Lambert, GH ;
Meeker, R ;
Licitra, E ;
Rafi, MM ;
Zhu, BT ;
Spaulding, H ;
Goodin, S ;
Toledano, MB ;
Hait, WN ;
Gallo, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (12) :785-791
[14]  
Dorai T, 1999, INT J CANCER, V82, P846, DOI 10.1002/(SICI)1097-0215(19990909)82:6<846::AID-IJC13>3.3.CO
[15]  
2-3
[16]  
Dorai T, 1997, PROSTATE, V32, P246, DOI 10.1002/(SICI)1097-0045(19970901)32:4<246::AID-PROS4>3.0.CO
[17]  
2-H
[18]  
Dorai T, 1997, ANTICANCER RES, V17, P3307
[19]   IDENTIFICATION OF IMMUNOSUPPRESSANT-INDUCED APOPTOSIS IN A MURINE B-CELL LINE AND ITS PREVENTION BY BCL-X BUT NOT BCL-2 [J].
GOTTSCHALK, AR ;
BOISE, LH ;
THOMPSON, CB ;
QUINTANS, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (15) :7350-7354
[20]   Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol) [J].
Gross, C ;
Stamey, T ;
Hancock, S ;
Feldman, D .
JOURNAL OF UROLOGY, 1998, 159 (06) :2035-2039